← Back to Search

Behavioral Intervention

Mindfulness Intervention for Autism Spectrum Disorder

N/A

Recruiting

Led By Nicole Matthews, Ph.D.

Research Sponsored by Southwest Autism Research & Resource Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Adolescents must be ages 13 to 18 years

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-intervention (8 weeks); 2-month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to develop interventions to help teenagers with Autism Spectrum Disorder (ASD) who also experience stress, anxiety, and depression.

Who is the study for?

This trial is for English-speaking adolescents aged 13-18 with a formal ASD diagnosis and their caregivers. Participants must commit to attending at least 7 of the 8 group meetings.

What is being tested?

The study tests 'MINDful TIME,' an intervention aimed at improving mental health symptoms like stress, anxiety, and depression in adolescents with Autism Spectrum Disorder (ASD).

What are the potential side effects?

Since this is a mindfulness-based intervention, there are no direct medical side effects; however, participants may experience emotional discomfort or fatigue during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 13 and 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-intervention (8 weeks); 2-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-intervention (8 weeks); 2-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (8 weeks); 2-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) Scores

Mean Change from Baseline in Children's Depression Inventory (CDI) Scores

Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) Scores

Secondary study objectives

Mean Change from Baseline in Adaptive Behavior Assessment System (ABAS-3) Scores

Mean Change from Baseline in Beck Youth Inventories (BYI) Scores

Mean Change from Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: MINDful TIME groupExperimental Treatment1 Intervention

8-week mindfulness-based intervention for adolescents with ASD and their caregivers. Weekly meetings will be held in-person and will last approximately 2-hours. Adolescents and their caregivers will be asked to engage in home practice outside of group meetings

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MINDful TIME

2023

N/A

~50

0 / 1Eligibility criteria met